to determine the purity of the sorted populations. E | Splenocytes from wild-type mice were stimulated with 2.5 μg/ml LPS for 5 days. B220 lo /CD138 + were FACS-purified (top) and subsequently re-analyzed to assess the purity (bottom). F | Splenic B-1a B cells from wild-type mice (pre-gated on CD19 + cells) were FACS-purified (top) and re-analyzed subsequently to assess the purity (bottom). Dead cells and doublets were removed also during purification of populations in Fig. S3C , E and F as shown in Fig. S3A . 
Supplemental Experimental Procedures Tamoxifen Administration
For inducible deletion of Prdm1, Prdm1 f/f mice were intercrossed with mb1-cre-ER T2 mice (Hobeika et al., 2015) and treated by gavage 3x every second day with 6 mg tamoxifen (Ratiopharm) dissolved in 20% ClinOleic (Baxter). Inducible deletion of Prdm1 in vivo was performed in compliance with animal research permit #1288 at the regional board of Tübingen, Germany). Mice were sacrificed and analyzed 6 months after induction with tamoxifen. Bcl2 Mm00477631_m1 Gapdh Mm99999915_g1
RACE
Total RNA was isolated from sorted cells and cDNA was synthesized as described in the main experimental procedures section concerning quantitative RT-PCR. A poly G-tail was added to the 3' end of the first strand cDNA using dGTP and TdT (New England Biolabs). Ig-µHC-specific and Ig-κLC-specific transcripts were amplified by nested PCR using genespecific oligos, anchor/adaptor oligos (enlisted in Table S6 ) and Q5 polymerase (New England Biolabs). The amplified PCR-products were subcloned in pJET1.2 blunt/vector (CloneJET PCR Cloning Kit, Thermo Fisher) and colonies were sequenced (GATC).
Sequences were analyzed by using the ImMunoGeneTics information system IMGT/V-Quest online tool. 
